e-Tendering {Procurement of Medicines} Important notice to prospective vendors/bidders registering with IREPS
Al the tenders of Indian Railways are being processed through E-Procurement System(IREPS) on the portal Like all others items, all the future tenders of Medicines are being planned to be uploaded on this portal very soon. Thereafter manual tenders wil not be invited.
Manual offers against e-Tenders shall be considered as invalid offers and shall be rejected summarily without any consideration.
Accordingly, it is necessary for all prospective bidders to be a registered user of IREPS website.
Please visit IREPS website and see helpdesk menu or contact with CRIS, New Delhi at 011-24105180/24102855 for any help in getting registered with IREPS.
A Class III-B digital signature certificate is pre-requisite for registration at IREPS website. This certificate can be obtained from any of the licensed certifying agencies whose addresses are available on the website
You are advised to get yourself registered with IREPS website and inform the details of same this office as early as possible.
For controller of Store Indian Railways Diesel Locomotive Works Varanasi-221004 MEDICAL BULLETIN- 11/2012
TENDER CLOSING TIME: 10.00 HOUR. OFFICE OF THE CONTROLLER OF STORES D.L.W. VARANASI Important Instructions to the Tenderers Terms & Conditions SPECIAL CONDITION: The supplier’s are requested to quote only branded medicines ‘Generic medicines ‘ shall not be considered. Such offers quoting ‘Generic medicines ‘or’ Branded Generic medicines’ shall be summirily ignored.” Firm should clearly indicate the Tender Number & date of opening on the top of the envelop as in the offer. The rates should be typed or written in ink, both in words and figures. Correction, if any, should be authenticated. The offer is liable to be ignored for any ambiguity in words and figures or unauthenticated corrections. The offer should be clearly for items asked for in regard to strength/volume of the item. The validity of the offers should be 90 (ninety) days from the date of tender opening. Firm should clearly quote the exact percentage of Sales Tax / VAT or any other taxes duties. In case of Sales Tax / any other duties / taxes not existing PO, same shall not be admitted at the later stage on any ground. Manufacturer’s name, Brand name, Formulation & other key details of the product must be indicated / attached in the offer. The firm should also clearly state that the drug offered is not branded genric/generic. Shelf life of medicines should be clearly mentioned in the offer for each item. Shelf life of medicines at the time of the supplies should not be less than 80% of the total shelf life. The procurement of medicines is as per new drug policy 2008, (as updated from time to time) of Health Directorate of Indian Railways from approved lists only. The approved list and other details are available on DLW’s website. Direct Quotation received from the principal firm, to whom the tender enquiry has been sent, or of its authorized dealer, only will be considered. However, direct quotations from OEMs /Principals are solicited. In case of offers from authorized dealers, the firm to whom the Tender enquiry has been sent must furnish a specific Authorization certificate. The Performa for same is enclosed. In case the authorized dealer is not available in the viscinity of Varanasi or nearby , the OEM’s should authorized their regional office quoting & supplying the drug on firm’s behalf. When offers are submitted by firms who are only marketing the product, such firms must indicate the manufacturers name in their offers. Latest authorization letter must be sent either in advance or along with the offer otherwise offer is likely to be rejected. The name, designation and contact number ( for verification) of the person who is issuing the authority should be clearly mentioned in the authorization letter. The person who is authoring distributor to quote should also submit a product list for which items they are authorized by the company for (generic / branded items). If there is any increase in prices please submit the price list to the COS office, DLW, Varanasi. One distributor/ agent, having more than one authorization, can quote only for one OEM / Manufacturer against a tender. In case he quotes for more than one authorized firm, all offers of such tenderer are liable to be rejected. Containers/Package should have endorsement “Indian Railways (or DLW/IR) – Not for Sale”. Medicines should be manufactured by the firm themselves which must be mentioned in labeling / packing. If the principal firm is marketing the medicine manufactured by other firm then name of principal firm must be endorsed in the packing of the product. Otherwise offer is not acceptable. Packing offered should be such as to withstand rough handling, transportation and exposure to extreme temperature and climatic conditions. Products do not which have paper packing are not acceptable. Drugs / Products of human origin should also have a certification stating “Free from HIV”, “Hepatitis ‘B’” and “Hepatitis ‘C’”, E, Anti haemolytic factors immunoglobulin, Human Albumin etc. The cost of sample testing analysis in the laboratories will be borne by the firm if found unsatisfactory. Delivery to be made to the Hospital Pharmacy Stores, Central Hospital, DLW, Varanasi, at the cost and risk of the firm. Inspection of medicines will be done at the Hospital Pharmacy Stores, Central Hospital, DLW, Varanasi. All rejected articles must be removed by the suppliers, at their own risks and costs within 7 days of the rejection notice. If the rejected material is not removed within the specified period, the DLW shall be at liberty to return the material on freight to pay basis to the firm without any further reference. If in the opinion of the inspecting officers, the material is not worth returning, the same shall be thrown away or destroyed. Neither claim of cost nor any compensation shall be entertained against these items. In case principal firm desire to effect the supply through its authorized dealer / supplier and request this office to send the Purchase Order to the authorized dealer / supplier, all legal and financial liabilities shall remain binding on the principal firm quoting rates. The Railway Administration reserves the right to take samples of any items supplied for analysis. Cost of the analysis will be borne by the supplier in case of unsatisfactory reports. Wherever, drug samples on analysis are found to be not conforming to standard, the suppliers are required to replace the whole quantity. L.D. shall be leviable as per rules for delayed supplies. Bill for 100% payment will be entertained after receipt and acceptance of the medicines/ items in good and sound conditions. The Railway Administration reserves the right to accept or reject any or all tenders, without assigning any reason, thereto and no claim shall be entertained in this respect. 27. The manufacturer / principal firms are requested to send their current Hospital price list of their products directly to the Controller of Stores, Diesel Locomotive Works, Varanasi and CMS /DLW/Varanasi. 28. All other terms and conditions shall be as per IRS CONDITIONS OF CONTRACT, as updated from time to time (available on the website of DLW). OFFICE OF THE CONTROLLER OF STORES D.L.W. VARANASI PROFORMA The Controller of Stores, Diesel Locomotive Works, Varanasi-221004 SUB: Authorization to quote against the special medical Bulletin No. Dated---------------- ********** We are forwarding the Special Medical bulletin No.______ Dated ________ to M/s. ________________________ to quote the competitive rates for our product, obtain orders, make the supply on our behalf and collect the payment directly. They are also advised to give the brake-up of the price quoted i.e. Basic price, Sales tax and other charges if any cess elements should be shown separately. Please note that no other party is authorized for quoting against the above mentioned bulletin quotation from any other sources on our behalf be ignored. M/s. _________________ __________________ -------------------------------- T.P.No._________________ FAX No.________________ GRAM _________________ The above certificate is only Specimen, therefore this certificate should be typed on your original letter head dully signed by the head of the firm and same should be sent to the COMTROLLER OF STORES, DIESEL LOCOMOTIVE WORKS, along with offer and one copy separately also . --------------- ------------- DIESEL LOCOMOTIVE WORKS, VARANASI SCHEDULE OF REQUIREMENTS FOR BULLETIN:- TENDER NO DESCRIPTION OF STORES DUE ON 05.07.2012 071231090 TAB ERYTHROMYCIN-500 MG. 071231100 TAB/CAP AMPICILLINE-250 MG. CLOXACILLINE/DICLUXACILLIN-250 MG. 071231110 TAB AZITHROMYCIN-100 MG. 071231120 TAB BALOFLOXACIN-100 MG. 071231130 TAB LINIZOLID-600 MG. 071231140 TAB/DT CEFEXIME-100 MG. 071231150 TAB CLOPIDOGREL-75 MG. 071231160 TAB ALPRAZOLAM-0.25 MG. 071231170 TAB ALPRAZOLAM-0.5 MG. 071231180 TAB HYDROCHLOROTHIAZIDE-12.5 MG. 071231190 TAB NEBIVOLOE-5 MG. 071231200 TAB ENALPRIL-5 MG. 071231210 TAB LOSARTAN POT-50 MG. 071231220 TAB LOSARTAN POT-50 MG. HYDROCHLOROTHIAZIDE-12.5 MG. 071231230 TAB METROPROLOL TARTRATE-50 MG. DUE ON 09.07.2012 071231240 TAB ATORVASTIN-10 MG. 071231250 TAB ATORVASTIN-20 MG. 071231260 TAB ISORBIDE DINITRATE-10 MG. 071231270 TAB ISORBIDE-5-MONONITRATE-20 MG. 071231280 TAB AMIDARONE-200 MG. 071231290 TAB TELMESARTAN-20 MG. 071231300 TAB TELMESARTAN-40 MG. HYDROCHLOROTHIAZIDE 12.5 MG. 071231310 TAB VARAPAMIL-40 MG. 071231320 TAB TRIMETAZEDINE 20 MG. 071231330 TAB PROPANOLOL-40 MG. 071231340 TAB RAMIPRIL-2.5 MG. 071231350 TAB RAMIPRIL-5 MG. 071231360 TAB AMLODEPINE-5 MG. 071231370 TAB AMLODEPINE-5 MG. ATENOLOL-50 MG. 071231380 TAB CARVIDILOL-6.25 MG. DUE ON 12.07.2012 071231390 TAB CARVIDILOL-12.5 MG. 071231400 TAB METROPROLOL SUCCINATE + AMLODEPINE-5 MG. 071231410 TAB ROSUVASTATIN-20 MG. 071231420 TAB ATENOLOL-50 MG. 071231430 TAB ACETXLESALICYLIC ACID-150 MG. 071231440 TAB QUITIAPIN-100 MG. 071231450 TAB GLIMPERIDE-1 MG. 071231460 TAB GLIMPERIDE-2 MG. 071231470 TAB METFORMINE HCL-500 MG. 071231480 TAB GLIPIZIDE-5 MG. 071231490 TAB MR/XR/SR METFORMINE HCL 1000 MG. 071231500 TAB DOXYFILLINE 400 MG. 071231510 R/CAP SALBUTAMOL SULFATE I.P-200 ug. 071231520 R/CAP FORMOTEROL FUMRATE-6 MCG. BUDESONIDE-200 MCG. 071231530 R/CAP TIOTROPIUM BR-18 MCG. DUE ON 16.07.2012 071231540 R/CAP BUDESONIDE-400 MCG. 071231550 TAB URSODEOXYCHOLIC ACID-150 MG. 071231560 TAB ORLISTAT-120 MG. 071231570 TAB MEFENAMIC ACID-250 MG. DROTAVERIN 071231580 TAB. ACELOFENAC-100 MG. PARACETAMOL-500 MG. 071231590 TAB FINESTRIDE-5 MG. 071231600 TAB DUTESTRIDE-0.5 MG. 071231610 TAB FENOFIBRATE 160-200 MG. 071231620 TAB TIZANIDINE-2 MG. 071231630 TAB FLAVAXATE-200 MG. 071231640 TAB CR/CROMO SODIUMVALPORATE 333 MG. VALPORIC ACID-145 MG. 071231650 TAB OXYCARBAZINE 450 MG. 071231660 TAB OXYCARBAZINE 300 MG. 071231670 TAB DANAZOLE-100 MG. 071231680 TAB FOLLIC ACID-5 DUE ON 19.07.2012 071231690 TAB/CAP BROMOCROPTIN MESYLOTE-2.5 MG. 071231700 TAB CONJUGATED ESTROGENS. 071231710 TAB LIVOCETRIZINE-5 MG. 071231720 TAB PARACETAMOL-325-500 MG. DICLOFENAC SOD.-50 MG. CHLORZOXONE-250-500 MG. 071231730 TAB/CAP GLUCOSAMINE SULPHATE-500 MG. 071231740 TAB FLUXETIN HCL-20 MG. 071231750 TAB XL/TR/SR. LITHIUM CARBONATE-400 MG. 071231760 TAB TRIFLUOPERAZINE-5 MG. TRIHEXYPHENIDYL-2 MG. 071231770 TAB TRIHEXYPHENEDYL 2 MG. 071231780 TAB SERTALINE-50 MG. 071231790 TAB LEVODOPA-250 MG. CARBIDOPA-25 MG. 071231800 TAB BISACODYL-5 MG. 071231810 INJ. EACH ML SUSPENSION CONTAINS 100 I.U.(3.5 MG) OF INSULIN ASPART-R-DNA ORIGINJ 30% AS SOLUBLE INSULIN AS PART AND 70% AS INSULIN AS PART PROTAMIN CRYSTAL. 3 ML PREFILLED PEN. 071231820 INJ. EACH ML CONTAINS 25% INSULIN LIPRO AND 75% INSULIN LIPRO PROTAMIN. SUSPENSION. EACH PREFILLED PEN OF 3 ML. DUE ON 23.07.2012 071231840 INJ. EACH PFS CONTAINS ENOXAPERIN-40 MG/0.4 ML. 071231850 INJ. EACH ML CONTAINS HUMAN INSULIN-40 I.U. VIAL OF 10 ML. 071231860 INJ. EACH 2 ML CONTAINS AMIKACIN-500 MG. VIAL OF 2 ML. 071231870 INJ. EACH VIAL CONTAINS CEFTRIAXONE-1 GM. TAZOBACTAM-125 MG. 071231880 INJ. EACH AMPULE CONTAINS NANDROLONE DECANOATE-25 MG. 071231890 INJ. EACH AMPULE CONTAINS NANDROLONE DECANOATE-50 MG. 071231900 INJ. EACH AMPULE CONTAINS IOTHALMATE-76% OR DIATRIAZONE MAGLUMINE AND DIATRIZOATE SODIUM-76%. 071231910 INJ. EACH PFS CONTAINS ERYTHROPOIETIN-400 I.U. 071231920 INJ. EACH VIAL CONTAINS HYDROCORTISONE SUCCINATE-100 MG. 071231930 INJ. EACH ML CONTAINS ONDANSCTRON-2 MG. AMPULE OF 2 ML. 071231940 INJ. COMBIPNATION OF TWO AMPULE (a) EACH 1.5 ML AMPULE CONTAINS VITAMIN-C-150 MG. (b) EACH ML CONTAINS VITAMIN B12-250 MCG, FOLIC ACID-0.7 MG. NIACINAMIDE-12 MG. 071231950 INJ. EACH AMPULE CONTAINS. THIAMIN-100 MCG + PYRIDOXIN-100 MG. +RIBOFLAVIN-5 MG. + VITA-B 12-100 MCG. + NICOTINAMIDE-100 MG + D- PAN THENOL-50 MG.-3 ML AMPULE. 071231960 INJ. EACH ML CONTAINS PROMETHAZINE-HCL-25 MG. AMPULE OF 2 ML. 071231970 INJ. EACH ML CONTAINS TRAMADOL HYDROCHLORIDE-50 MG. AMPULE 071231980 INJ. EACH PFS CONTAINS HYDROXYPROPYLMETHYLCELLULOSE-2%. DUE ON 26.07.2012 071231990 INJ. EACH BOTTLE CONTAINS SODIUM CHLORIDE-0.9% BOTTLE OF 500-540 ML. 071232000 INJ. EACH BOTTLE CONTAINS RINGER LACTATE-BOTTLE OF 500-540 ML 071232010 INJ. EACH VIAL CONTAINS PANTOPRAZOLE-40 MG. 071232020 INJ. EACH VIAL CONTAINS VANCOMYCIN-500 MG. 071232030 INJ. EACH PFS CONTAINS HUMAN PAPILLOUMS VIRUS VACCINE CANTAIN HPV TYPE 16L1, PROTIEN 20 MICROGRAM AND HPV TYPE-18L1 PROTEIN 20 MECROGRAMS WITH ADIUVANT-SYSTEM ASO4-0.5 ML. 071232040 SYP. EACH 5 ML CONTAINS AMOXYCILLINE -200 MG. CLAVULANIC ACID- 28.5 MG. 30-60 ML PH. 071232050 SYP. EACH 5 ML CONTAINS AZITHROMYCIN-200 MG. 15-30 ML PHAIL. 071232060 SYP. EACH 5 ML CONTAINS CEFACLOR-125 MG. 30 ML PHAIL. 071232070 SYP. EACH 5 ML CONTAINS CEFADROXIL-250 MG. 071232080 SYP. EACH 5 ML CONTAINS CEFPODOXIM-100 MG. 30-60 ML PH. 071232090 SYP. EACH 5 ML CONTAINS OFLOXACIN-50 MG. ORNIDAZOLE-125 MG. 30 ML PHAIL. 071232100 SYP. EACH 5 ML CONTAINS DISODIUM HYDROGEN CITRATE-1.53 GM. PHAIL OF 100-120 ML. 071232110 SYP. EACH 15 ML CONTAINS MILK OF MAGNESIA-3.75 ML. LIQUID PARAFTIN-11.25 ML. OR PHENOLPTHELIN-11.25 ML. BOTTLE OF 170-200 ML. 071232120 SYP. EACH 15 ML CONTAINS LACTULOSE-10 GM. BOTTLE OF 100-150 ML 071232130 SYP. EACH 15 ML CONTAINS LACTITOLE MONOHYDRATE-66.67% BOTTLE OF 100-130 ML. DUE ON 01.08.2012 071232140 SYP. EACH 5 ML CONTAINS IBUPROFIN-100 MG. PARACETAML-125 MG. 60 ML PHAIL. 071232150 EACH JAR CONTAINS GLUTARAL DEHYDE-2%-5% 28 DAYS LIFE. JAR OF 071232160 SOLUTION CONTAINS CHLOROXYLENOL-4.8% TENPINOL-9% ALCOHOL ABSOLUTE-13.1%. 500 ML BOTTLE OF 5 LTR. JAR. 071232170 SYP. EACH 5 ML CONTAINS ONDANSETRON-2 MG. PHAIL OF 30 ML. 071232180 SYP. EACH 5 ML CONTAINS FEXOFENADINE-30 MG. PHAIL OF 60 ML. 071232190 SYP. EACH 5 ML CONTAINS SALBUTAMOL-2 MG. PHAIL OF 100-120 ML. 071232200 SYP. EACH 5 ML CONTAINS THEOPHYLIN-50 MG. + SALBUTAMOL-1 MG. BOTTLE OF 60-100 ML. 071232210 SYP. EACH 5 ML CONTAINS BROMOHEXIN-4 MG. GUAPHENSIN-50 MG. CHLORPHENERAMINE MALEATE-2 MG. BOTTLE OF 100 ML. 071232220 SYP. EACH 5 ML CONTAINS GUAPHENSIN-50-60 MG. TERBUTALIN-1.25-2 MG. BROMOHEXIN-2-4 MG + MENTHOL-0.5-1 MG, BOTTLE OF 100-120 ML. 071232230 SYP. EACH 5 ML CONTAINS DIPHENHYDRAMIN-14.08 MG. AMMONIUM CHLORIDE-138 MG + SODIUM CITRATE-57 MG. MENTHOL-1.14 MG. BOTTLE OF 100-120 MG. 071232240 SYP. EACH 5 ML CONTAINS. CHLORPHENIRAMINE MALEATE-2.5-3 MG. + AMMONIUM CHLORIDE-125 MG-150 MG + SODIUM CITRALE-55-60 MG. BOTTLE OF 100-120 MG. 071232250 SYP. EACH 5 ML CONTAINS DEXTROMETHORPHAN-10 MG. CHLORPHENIRAMINE MALEATE-4 MG. PHAIL OF 50-100 ML. 071232260 SYP. EACH 10 ML CONTAINS SUCRALFATE-1 GM. BOTTLE OF 100-200 ML 071232270 EACH BOTTLE MOUTH WAS CONTAINS BENZADAMINE-0.15% W/V. BOTTLE OF 100-150 ML. 071232280 EACH BOTTLE MOUTH WASH CONTAINS THYMOL-0.06% + EUCALYPTAL OIL -0.09% + MENPHOL-0.04% PHAIL OF 85-120 ML. DUE ON 06.08.2012 071232290 EACH MOUTH WASH CONTAINS CHLORHEXIDINE-0.2% W/V. PHAIL OF 100-120 ML. 071232300 SYP. EACH 5 ML CONTAINS ELEMENTAL CALCIUM-125 MG +V ITA-D3- 62.5 MG.CAGNESIUM- 10 MG ,MANGANESE-0.5 MG , BORAX-2.5 MG, ZINC- 2.5 MG BOTTLE OF 150. 071232310 EYE DROP CONTAINS OFLOXACIN-0.3% PHAIL OF 5-10 ML. 071232320 EACH EYE DROP CONTAINS TOBRAMYCIN-0.3% PHAIL OF 5-10 ML. 071232330 EACH EYE ONT CONTAINS TOBRAMYCIN-0.3% TUBE OF 3-10 GM. 071232340 EACH OPTHO-CAP CONTAINS CHLORAMPHENICAL-1%. 071232350 EACH EYE DROP CONTAINS FLURBIPROFIN-0.03% PHAIL-5-10 ML. 071232360 EACH EYE DROP CONTAINS KETOTIFIN-0.5 MG. PHAIL OF 5-10 ML. 071232370 EACH EYE DROP CONTAINS TIMOLOL- 0.5% PHAIL OF 5-10 ML. 071232380 EACH EYE DROP CONTAINS TROPICAMIDE-0.8% PHENYLEPHIRINE-HCL- 5% PHAIL OF 5-15 ML. 071232390 EACH EYE DROP CONTAINS POLYVINYL ALCOHOL-1.4% POVIDONE-0.6% PHAIL OF 5-10 ML. 071232400 EACH EYE DROP CONTAINS MOXIFLOXACIN-0.5% PHAIL OF 5-10 ML. 071232410 EACH EYE DROP CONTAINS MOXIFLOXACIN-0.5% PREDNISOLONE ACCTALE-1% PHAIL OF 5-10 ML. 071232420 EACH EYE DROP CONTAINS MOXIFLOXACIN-0.5% KCTORALAC. PHAIL OF 5-10 ML. 071232430 EACH EYE DROP CONTAINS SODIUM CARBOXYMETHYL. CELLULOSE-0.5 MG. PHAIL OF 5-10 ML. DUE ON 09.08.2012 071232440 EACH EYE DROP CONTAINS NAPHAZOLIN-0.056% CHLORPHENIRAMIN MALEATE-0.01% PHAIL OF 5-10 ML. 071232450 EACH NASAL SPARY CONTAINS BUDISONIDE-64 MCG PER 1 DOSE 200 METRE DOSE. 071232460 EACH NASAL SPARY CONTAINS FLUTICASONE PROPIONATE-0.05% 100 METERED DOSE 071232470 EACH EAR DROP CONTAINS CHLORAMPHENICOL-5%, BECLOMETHASONE DIPROPIONATE-0.025%, CLOTRIMAZOLE-1%, LIDOCAINE-1.73%. PHAIL OF 5-10 ML. 071232480 EACH EAR DROP CONTAINS. PARADICHLOROBENZINE-2%, BENZOCAINE-2.7%, CHLOROBUTANOL-5%, TURPENTINE OIL-15%. PHAIL OF 5-10 PH. 071232490 EACH INHALER CONTAINS. LEVOSALBUTAMOL-100 MCG/1 PUFF 200 METERD DOSE (CFC FREE). 071232500 EACH INHALER CONTAINS BUDESONIDE-100 MCG/PUFF 100 METERED DOSE. (CFC FREE). 071232510 EACH INHALER CONTAINS TIOTROPIUM BROMIDE-9 MCG/PUFF. 120 METER DOSE CONSTER. (CFC FREE). 071232520 EACH INHALER CONTAINS. BUDESONIDE-400 MCG. FORMOTEROL- FUMARATE-6 MCG/PER PUFF, 120 METERED DOSE CONSTER (CFC FREE) 071232530 CREAM CONTAINS BETAMETHASONE DIPROPIONALE-0.025% TUBE OF 12-25 GM. 071232540 CREAM CONTAINS BECLOMETHASONE DIPROPIONALE-0.025%, NEOMYCIN-0.5%. TUBE OF 15-20 GM. 071232550 CREAM CONTAINS BETAMETHASONE-0.025%. SALICYLIC ACID-3%. TUBE OF 15-20 GM. 071232560 CREAM CONTAINS MICONAZOLE-2%. TUBE OF 15-20 GM. 071232570 CREAM CONTAINS CLOTRIMAZOLE-1%. BECLOMETHASONE- DIPROPIONATE-0.025%. TUBE OF 10-20 GM. 071232580 EACH CREAM CONTAINS FUSIDIC ACID-2%. TUBE OF 5-15 GM. 071232590 EACH CREAM/ONT. CONTAINS MUPIROCIN-2%. TUBE OF 5-20 GM. DUE ON 17.08.2012 071232600 @ EACH CREAM CONTAINS CLOBETASOL PROPIONATE-0.05%. TUBE OF 10-12 GM. 071232610 EACH CREAM CONTAINS FRAMYCETIN SULPHATE-1%. TUBE OF 20-30 071232620 EACH CREAM CONTAINS FRAMYCITIN SULPHATE-1%. DECXAMETHASONE ACETATE—0.1%. CLOTRIMAZOLE-1%. TUBE OF 20- 30 GM. 071232630 EACH GEL CONTAINS. DICLOFENAC-1%. TUBE OF 15-30 GM. 071232640 EACH GEL CONTAINS PIROXICAM-0.5%. TUBE OF 15-30 GM. 071232650 JELLY CONTAINS LIDOCAINE-2%. TUBE OF 10-20 GM. 071232660 EACH CREAM/ONT CONTAINS BIFONAZOLE-1%. TUBE OF 10-20 GM. 071232670 EACH ONT CONTAINS HYDROCORTISONE ACETATE-5.58 MG., FRAMYCETIN SULPHATE-10 MG. HEPARIN-100 I.U. ESCULOSIDE-10 MG. ETHYLAMINOBENZOATE-10 MG, BUTYLAMMINOBEZOATE-10 MG. TUBE OF 10-20 GM. 071232680 EACH NASAL DROP CONTAINS XYLOMETAZOLINE-0.05%. PHAIL OF 10-15 071232690 EACH NASAL DROP CONTAINS XYLOMETAZOLINE-0.1%. PHAIL OF 10-15 DUE ON 21.08.2012 071232700 EACH INHALER CONTAINS. FLUTICASONE PROPIONATE-250 MCG. SALMETEROL-50 MCG/PUFF 120 METERED DOSE PER COSTER. (CFC FREE). 071232710 INJ EACH ML CONTAINS 100U. INSULIN DETEMIR (R-DNA ORIGIN) 14.2 MG. 3 ML PFS. 071232720 INJ EACH ML SOLUTION CONTAINS 100 U (3.5 MG) OF INSULIN ASPART. (r-DNA ORIGIN). 3 ML PFS. 071232730 SYP. EACH 10 ML CONTAINS ACTIVATED DIMETHICON. HYDROXIDE-100- 250 MG + DRID ALLUMINIUM HYDROXIDE-150-250 MG + SORBITOL SOLUTION-75%. BOTTLE OF 170-200 ML. 071232740 SYP. EACH 10 ML CONTAINS MAGNESIUM HYDROXIDE-185 MG + SIMETHICENE-50-100 MG.+ SODIUM CARBOXYMETHYLCELLULOSE-100 MG + DRIED ALUMINIUM HYDROXIDE GEL-830-1000 MG. BOTTLE OF 170 ML-200 ML. 071232750 SYP. EACH 15 ML CONTAINS FERRIC AMMONIUM CITRATE-150-160 MG. FOLIC ACID-0.5-1.5 MCG. VIT B12-7.5-15 MCG. BOTTLE OF 200 ML. 071232760 SYP. EACH 15 ML CONTAINS. THIAMIN-2-4 MG., RIBOFLAVIN -2.54 MG. + PYRIDOXIN-2 MG., NIACINAMIDE-20 MG., D-PANTHENOL-6 MG. + ASCORBIC ACID-75 MG. BOTTLE-100-200 ML. 071232770 INJ. EACH ML CONTAINS RABIES ANTIGEN >- 2.5 I.U. ADSORBED ONTO ALUMINIUM PHASPHATE. ADAPTED AND GROWN ON HUMAN DIPLOID CELLS & INACTIVATED BY USING B. PROPIOLACTONE. DUE ON 24.08.2012 071232780 TAB CEFEXIME-200 MG. 071232790 TAB/CAP. AMOXYCILLIN-500 MG. CLAVULANIC ACID-12.5 MG. 071232800 TAB. CEFEXIME-200 MG. OFLOXZCIN-200 MG. 071232810 TAB. CLARITHROMYCIN-500 MG. 071232820 TAB ATORVASTIN-40 MG. 071232830 TAB/GIT/ORS PRAZOCIN-2.5 MG. 071232840 TAB/GIT/ORS PRAZOCIN-5 MG. 071232850 TAB PERINDOPRIL-4 MG. AMLODEPINE-5 MG. 071232860 TAB TELMESARTAN-40 MG. 071232870 TAB. NICORANDIL-5 MG. 071232880 TAB/SR. GALENIC FORMULAION BASED ON HYDROPHILIC MATRIX INDOPAMIN SR-1.5 MG. 071232890 TAB OLMESARTAN-40 MG. 071232900 TAB SEXAGLIPTIN-5 MG. 071232910 TAB URSODEOXYCHOLIC ACID-300 MG. 071232920 TAB/CAP TAMSULOSIN HCL 0.4 MG. 071232930 TAB/CAP. TAMSULOSIN-0.4 MG. DUTESTRIDE-0.5 MG. 071232940 TAB VIT B1-15 MCG, B1-10 MG B2-10 MG. NICOTINAMIDE-100 MG, CALPANTHONATE 10 MG.-12.50 MG., B6-3 MG.FOLLIC ACID-1.5 MG. VITC- 150 MG. 071232950 TAB. FEXOFENADINE-120 MG. 071232960 TAB TRYPSIN-CHYMOTRY-PSIN-2 LAKHS. ARMOUR UNIT OF ENRY MATIC ACTIVITY. 071232970 DIOSMIN-450 MG. HESPERIDON-50 MG. 071232980 TAB. ATORVASTIN-80 MG. 071232990 TAB TRYPSIN/CHYMOLRYPSIN-50,000 I.U. DICLOFENAC SOD-50 MG. DUE ON 27.08.2012 071233000 TAB/CAP PRIMOSAOIL-1000 MG. 071233010 TAB HYDROXYZINE HCL-25 MG. 071233020 TAB/R MEBEVERINE HCL/R. 071233030 TAB PHENTOIN SOD-100 MG. 071233040 TAB TRIBASIC CAL. PHOSPHOTE -0.38 GRAM eg CALCIUM-125 MG +VIT D3-400 I.U. 071233050 TAB TRAMADOL HCL-37.5 MG ACETAMINOPHEN-325 MG. 071233060 TAB ACETAZOLAMIDE 250 MG 071233070 TAB CINRAZINE-75 MG 071233080 TAB PROCHLORPERAZINE-5MG 071233090 TAB LAMOTRIZINE-50 MG 071233100 TAB METHYLCOBALAMINE-1500 MG 071233110 TAB THIOCOLCHICOSIDE -4 MG DICLOFENAC-50 MG 071233120 TAB GABAPENTIN-300 MG 071233130 TAB THYROXIN SOD -100 MG 071233140 TAB THYROXIN SOD-50 MG 071233150 TAB THYROXIN SOD-25 MG DUE ON 29.08.2012 071233160 TAB SALAZOPYRIN-500-1000 MG 071233170 TAB ACETYLE SALIEYLIC ACID-75 MG 071233180 CAP FERROUS FUMRATE-200 MG FOLLIC ACID-0.3 MG VIT B12-10 MCG, ZNSO4-6.18 MG 071233190 TAB PIRACETAM 800-1200 MG 071233200 TAB ZINKGOBILOBA 40 MG 071233210 TAB ELEMENTAL CALCIUM -500 MG VIT D3 -250 IU 071233220 TAB SODIUM ALENDRONATE-70 MG 071233230 TAB DEFAZACORT -6 MG 071233240 TAB ACICLOVIR-800 MG 071233250 TAB CARBAMAZEPINE-200 MG 071233260 TAB/SR CARBAMAZEPINE 200MG 071233270 TAB PENTAPERAZOLE-40 MG DOMPERIDON-10 MG 071233280 TAB LAMITHINE-L ASPARATE-150MG 071233290 TAB RANOLAZINE-500 MG 071233300 FERROUS FUMRATE-152 MG, FOLLIC ACID-1500 MCG DUE ON 03.09.2012 071233310 TAB ALFACALCIDOL-0.25MG 071233320 TAB OXYCARBAZINE 600 MG 071233330 TAB CLONIDINE-100 MCG 071233340 TAB BETAHISTADIN-48 MG 071233350 TAB ALISKIRAN-150 MG 071233360 TAB GLIMPERIDE-4MG METFORMINE HCL-500 MG 071233370 TAB BETAHISTADIN -16 MG 071233380 TAB/CAP LANSOPRAZOLE-30 MG 071233390 TAB TEDROXY PROGESTERIN -10 MG 071233400 TAB CLONAZEPAM-0.5 MG 071233410 TAB DRIED AL. HYDROXIDE GEL-300 MG + AL. SILICATE-50MG+ SEMITHICON -25MG + MG. HYDROXIDE-25MG 071233420 TAB NORTHESTERON-5MG 071233430 TAB CHLORODIOAZEPOXIDE CLIDINIUM BR- 071233440 TAB CITICOLINE-500 MG DUE ON 06.09.2012 071233450 TAB CLOBAZAM-10MG 071233460 TAB DONEPEZIL-5-10MG 071233470 TAB VOGLIBOSE-0.2MG 071233480 TAB. VOGLIBOSE-0.3MG 071233490 SACCHET EACH SACCHET CONTAINS CHOLECALCIFEROL-1 G. 071233500 TAB. PIOGLITAZONE-15 MG. 071233510 CAP/TAB. EACH HARD GELATIN CAP. CONTAINS- SPORES OF POLYANTI BIOTIC RESISTANT BASILLUS CLAUSI-2 BILLION. 071233520 TAB. MONTELUKAST SOD-10 MG. LIVOCETRIZINE-5 MG. 071233530 TAB. NICOUMALONE-I.P.-1 MG. 071233540 TAB. CLOBAZAM-5 MG. 071233550 TAB. MEFLOQUINE-100 MG. 071233560 TAB. TRENEXAMIC ACID-500 MG. MEFENAMIC ACID-500 MG. 071233570 TAB. RAMIPRIL-2.5 MG. HYDROCHLOROTHIAZIDE-12.5 MG. DUE ON 10.08.2012 071233580 TAB CARBAMAZOLE-5 MG. 071233590 TAB PANTAPERAZOLE-40 MG. 071233600 TAB/KIT MISOPROSTOL-200 MCG. 071233610 TAB/KIT MIFEPROSTONE-200 MCG. 071233620 TAB GAMFIBROZIL-300 MG. 071233630 SACCHET. 3 GRAM PKT CONTAINS L-OMITHIN-L-ASPARATE-5 G. 071233640 TAB ZOLPIDEM 12.5 MG. 071233650 TAB ETOFYLLINE-115 MG. THEOPHYLLINE-35 MG. 071233660 TAB MONTEULOKAST-10 MG. FEXOFENADONE-120 MG. 071233670 TAB/M/D. ONDENSTERON-4 MG. (M/D. TABLET). 071233680 TAB CLOPIDOGREL-75 ACETYLE-SALICYLIC ACID-75 MG. 071233690 SYP. 5 ML CONTAINS CHLORPHENIRAMINE-MALEAT-40-50 MG.+ CODINE PHOSPHATE-10-15 MG. PHAIL OF 100-150 ML. 071233700 SYP. EACH 5 ML CONTAINS LEVOCLOPERASTINE-FENDIZOATE-35.4 MG. + ASPARTARNE-8 MG. PHAIL OF 100-120 ML.
Fortbildungsreferat bei der Kreisärzteschaft Calw am 6. November 2002 Einleitung: In den letzten Jahren wurden 8 neue Antikonvulsiva mit unterschiedlichen Wirkmechanismen zu Behandlung von epileptischen Anfällen im Erwachsenenalter zugelassen. Die Indikation lautet in der Regel: Zusatz-Behandlung („add-on“) von komplex-fokalen Anfällen, die schwierig einzustellen sind. Wenige Medika
A. Short answers to yes/no questions: Instructions: In these dialogues, the long answer is given in parentheses. Look at the long answer and then write the appropriate yes/no question and short answer to complete each dialogue. Do not use a negative verb in the question. Example : A: Do you know my brother? B: No, I don’t. (I don’t know your brother.) 1. A: ______